Michael Schwarz

14PUBLICATIONS
52CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersHaematological tumoursRespiratory diseasesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.

Georg Semmler, Sonia Alonso López, Monica Pons

|Dec 21, 2024
Letter: Insulin-Like Growth Factor-1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver-Related MortAlity-Authors' Reply.

Lukas Hartl, Michael Schwarz, Thomas Reiberger

|Nov 07, 2024
Chronic hepatitis E in a patient after chimeric antigen receptor-T-cell treatment for diffuse large B-cell lymphoma and rapid progression towards decompensated liver cirrhosis.

Michael Schwarz, Behrang Mozayani, Michael Trauner

|Nov 04, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply.

Lukas Hartl, Michael Schwarz, Benedikt Simbrunner

|Oct 01, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project.

Lorenz Balcar, Michael Schwarz, Livia Dorn

|Sep 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality.

Lukas Hartl, Michael Schwarz, Benedikt Simbrunner

Pageof 3

Frequent Collaborators

13 joint publications

Thomas Reiberger

9 joint publications

Mattias Mandorfer

8 joint publications

Lukas Hartl

8 joint publications

Mathias Jachs